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Background: Currently there is an urgent need to develop new classes of antimicrobial agents with
different mechanisms of action from conventionally antibiotics used for the control of pathogenic mi-
croorganisms. The acylpolyamine called VdTX-I was isolated from the venom of the tarantula Vitalius
dubius, and ﬁrst described with activity as an antagonist of nicotinic cholinergic receptors. The main
objective of this study was to investigate the antimicrobial activity found in the venom of the spider, with
emphasis on the toxin VdTX-I.
Methods: Antimicrobial assays were performed in 96 well plates culture against 14 micro-organisms
(fungi, yeasts and bacteria), which were tested concentrations from 0.19 to 100 μM of VdTX-I. After
qualitative analysis, dose-response curve assays were performed in bacterial kill curve using MTT reagent
and hemolytic assay.
Results: The antimicrobial activity of the VdTX-I toxin was observed in 12 tested species of Candida,
Trichosporiun, Staphylococcus and Micrococcus. The toxicity had a dose-response at 3.12 mM – 100 μM in
Candida albicans, Candida guillermondii, Micrococcus luteus and Escherichia coli. VdTX-I took about 5 min
to inhibit bacterial growth, which was faster than streptomycin. The toxin showed no hemolytic activity
between 0.19 and 100 μM. At 2.5 mg/mL of toxin it was observed no growth inhibition against a mam-
malian cell lineage.
Conclusions: The VdTX-I toxin has a signiﬁcant antimicrobial activity, with broad spectrum, and is ex-
perimentally inert to mammalian blood cells.
General Signiﬁcance: This paper explores the antimicrobial potential of the spider toxin VdTX-I, which
can provide a new model to design new antimicrobial drugs.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The introduction of antibiotics was largely responsible for the
dramatic decline in the mortality rate of diseases reported in de-
veloped countries. However bacteria are remarkably adaptable to
environmental stresses and have evolved at least one mechanism
of resistance for all 17 classes of antibiotics developed to date [1].
Many in use active molecules were obtained from organisms. One
of the ﬁndings are the biogenic amines (polyamines, acylpolyamines),
which are particularly powerful and have a wide spectrum of action.
Typically its activity is not restricted to a single type of pathogen as
Gram-positive and Gram-negative bacteria, fungi, protozoa [2].B.V. This is an open access article u
ila Buarque, CEP 01221-020,
.br (T.A.A.d. Rocha e Silva).Polyamines are found in nearly all living organisms and cell-
sand can be well studied as putrescine, spermidine and spermine.
It contains polycations that can interact with polyanionic macro-
molecules such as DNA, RNA, ion channels and protein kinases.
This interaction promotes the regulation of gene expression, post-
translational modiﬁcations, and alterations in the cell cycle, cell
membrane structure and function. Thus, the poliamines also play
an important role in the regulation of growth, development and
function of animals, plants and microorganisms. In addition, the
concentration and composition may present a great variation ac-
cording to the cell type and the physiological conditions of the
organism [3].
Further present in many organisms, the polyamines can have
several applications such neuroprotective effect in animal models of
multiple sclerosis [4], antimalarial and antitripanossomal activity
[5,6] and have high efﬁciency and low toxicity against Chagas dis-
ease [7]. Synthetic polyamines can act as antimicrobial agents thatnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Minimum Inhibitory Concentration (MIC) of the toxin VdTX-I.
Microorganism MIC
Aspergilus niger (isolated) ND
Cladosporium sp. (isolated) 6.25–12.5 mM
Trichosporium sp. IOC4569 6.25–12.5 mM
Micrococus luteus A270 6.25–12.5 mM
Staphylococus aureus ATCC29213 6.25–12.5 mM
Staphylococus epidermides ATCC12223 6.25–12.5 mM
Enterobacter cloacae β12 50 mM
Escherichia coli ATCC 25922 6.25–12.5 mM
E. coli D31 6.25–12.5 mM
Candida albicans MDM8 6.25–12.5 mM
Candida parapsiliosis IOC4564 ND
Candida guillermondii IOC4557 6.25–12.5 mM
Candida tropicalis IOC4560 6.25–12.5 mM
Candida glabata IOC4565 6.25–12.5 mM
Candida krussei IOC4559 6.25–12.5 mM
ND¼Not Detected in test concentration.
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their breakage. It can also be covalently attached to the surface of
medical implants, surfaces of medical materials, in order to prevent
adhesion or growth of microorganisms [8].
In the venom of spiders, identiﬁcation of antimicrobial com-
pounds is constant, as in the case of Cupiennius salei [9,10], and
Ornithoctonus hainana [11]. The antibiotic property is presumed to
avoid infection by bacteria, fungi and yeasts on feeding, since
these animals carry out extracorporeal digestion [11]. Never-
theless, all cited molecules are peptides.
Spider venoms are known as sources of many natural products,
particularly acylpolyamines. Have been characterized in the ve-
nom of the spider Agelenopsis aperta, Hololena curta and Para-
coelotes birulai [12–14]. Biogenic amines of low molecular weight
such as putrescine, cadaverine, spermidine and spermine were
characterized in the venom of spiders mygalomorph Scorda gri-
seipes, Atrax robustus, and species of tarantulas spiders Dugesiella
hentzi, Aphonopelma emilia and two other species Aphonopelma
[15,16].
Among species of São Paulo state, the venom of tarantula Vi-
talius dubius, a variety of peaks seen in reversed phase chroma-
tography and the range of molecular masses observed after SDS-
PAGE and immunoblotting indicated that the venom of this spider
contained several components, especially low molecular weight
indicating a large amount of peptides. [17]
Rocha-e-Silva et al. puriﬁed the polyamine VdTX-I, arising from
tarantula spider V. dubius, and showed that this toxin was capable
of producing reversible blockade in biventer cervices neuromus-
cular preparations. [18]
In this context, this paper proposes to evaluate the anti-
microbial activity of the toxin VdTX-I.2. Materials and methods
2.1. Spiders
The spiders were obtained at Centro de Animais Peçinhentos
René D´ávila, Itu, Brasil.. After identiﬁcation, the animals were
brought to the Butantan Institute, where they were kept in a vi-
varium of Silva Jr´s Laboratory. The venoms of spiders are ex-
tracted by electro stimulation, as described by Rocha-e-Silva [17].
2.2. Fractionation and puriﬁcation
The venom of V. dubius and VdTX-I were obtained following the
method proposed by Rocha-e-Silva [18] protocol.
2.3. Antimicrobial activity
For antimicrobial activity test the bacterial growth in liquid
medium assay was used [19]. In a 96-well micro plate,10 μL of the
toxin or water (control) were applied to wells of 90 μL of the
culture medium PB (Poor Broth) used for bacteria and PDB (Potato
Dextrose Broth) used for fungi and yeasts in the logarithmic phase
of growth. The absorbance of the cultures was measured after 18 h
incubation at 30 °C on a micro plate reader IEMS (LABSYSTEM™)
and Victor3 (1420 Multilabel Counter/Victor3 – Perkin Elmer) at
595 nm.
The VdTX-I toxin was tested against 15 microorganisms at
concentrations from 0.19 to 100 mM (Aspergilus niger, Cladosporium
sp., Trichosporium sp. IOC4569, Micrococus luteus A270, Staphilo-
cocus aureus ATCC29213, Staphilococus epidermides ATCC12223,
Enterobacter cloacae β12, Escherichia coli ATCC 25922, E. coli D31,
Candida albicans MDM8, Candida parapsiliosis IOC4564, Candida
guillermondii IOC4557, Candida tropicalis IOC4560, Candida glabataIOC4565 and Candida krussei IOC4559).Furthermore, quantitative
analysis (dose-response) was performed and the dose-response
curve was performed using 4 microorganism (C. albicansMDM8, C.
guillermondii IOC4557, M. luteus A270 and E. coli ATCC 25922).
Since it is a qualitative test, the Minimum Inhibitory Con-
centration (MIC) is between the highest value without activity and
the lowest active concentration, and thereby presented as a nar-
row range of concentrations.2.4. Kill curve assay
To evaluate the minimum time that VdTX-I toxin acts on mi-
croorganisms, the kill curve assay was performed according to, the
protocol described by Wang [20] with modiﬁcations.
For this assay, 50 μM toxin were added 200 μL of suspension of
E. coli D31 and M. luteus A270 at a concentration of 106 CFU and
were incubated at 37 °C at times 0, 5, 10, 15, 30, 60, 120, 180 and
240 min. After incubation were added 20 μL of a solution at
5 mg/mL of 3-(4,5-imethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) and incubated at 37° C for 20 min.
Then, the tubes were centrifuged at 10,000g for 30 s and the
supernatant was removed leaving the formazan crystals at the
bottom of the tubes. The crystals were dissolved in 1 mL of iso-
propanol and this volume was transferred to glass tubes, and
further added 1.5 mL of isopropanol to obtain a ﬁnal volume of
2.5 mL. Reading was performed in 96-well plates at 595 nm. As a
positive control the same procedure was performed with 20 μL of
antibiotic Streptomycin instead toxin, and as negative control
20 μL of ultra-pure H2O was used.2.5. Hemolytic activity
In this evaluation, human erythrocytes were collected in 0.15 M
citrate buffer pH 7.4 and washed 3 times by centrifugation at 700g
with PBS pH 7.4. After the last centrifugation the cells were re-
suspended in PBS pH 7.4. Aliquots at a concentration of 0.19 to
100 mM VdTX-I were added to the 96 well plate with bottom “U”,
where in each well containing 50 mL of a suspension of ery-
throcytes to 3%. After that, the samples were incubated at room
temperature for 3 h. Hemolysis was determined by reading ab-
sorbance at 595 nm of each well in a bed of plates (Titertek Mul-
tiskan Elfa B, Finland). As a positive control was used Triton, and as
negative control was used PBS only.
Fig. 1. Dose-response curve of the toxin VdTX-I against four species of microorganisms. (Left)C. albicansMDM8 and C. guillermondii IOC4557. (Right)M. luteus A270 and E. coli
ATCC 25922. The points represent7SEM, n¼3.
Fig. 2. Kill curve assay testing VdTX-I. (Left) Test of VdTX-I against M. luteus A270 (Right) Test of VdTX-I against E. coli ATCC 25922. The points represent7SEM, n¼3. *
Signiﬁcant difference from the starting point of the same group. ♯ Signiﬁcant difference compared to streptomycin group at the same point. † Signiﬁcant difference compared
to the control group at the same point. po0.05.
Fig. 3. Hemolytic activity of VdTX-I. It is not observed signiﬁcant hemolysis at any
concentration tested. The points represent7SEM, n¼3.
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The cytotoxicity assay was performed in K562 cells (human
erythroleukemia) grown in RPMI-1640 culture medium supple-
mented with 10% fetal bovine serum, and 1% of solution antibiotic-
antimicotic made with 10,000 U of penicillin, 10 mg de strepto-
mycin e 25 μg amphotericin B, in an incubator at 37 °C with 5%
CO2. The number of K562 cells the culture was set to 2106 viable
with 96% in three bottles (12.5 cm2). Two concentrations of VdTX-I
(2.5 μg/ml and 20 μg/ml) and the controls were applied. The
counting was performed by hemocytometer method by exclusion
of trypan blue and the cytotoxic potential, deﬁned based on the
control curve at time 24 and 48 h [21].2.7. Statistical analysis
The results were expressed as mean7error of mean (SEM), and
statistical comparisons were made using analysis of variance
(ANOVA) by Tukey test or Student t test to compare means. A value
of po0.05 indicated signiﬁcance.
Fig. 4. Cytotoxic activity of the toxin VdTX-I against K562 cultured cells. (Left) Concentration of 2.5μg/mL VdTX-I. (Right) Concentration of 20 μg/mL VdTX-I. * Signiﬁcant
difference from the starting point of the same group. ♯ Signiﬁcant difference compared to streptomycin group at the same point.
R. Sutti et al. / Biochemistry and Biophysics Reports 4 (2015) 324–328 3273. Results
The toxin VdTX-I showed activity against 13 microorganisms
tested, mostly in the concentration of 12.5 to 100 μM (Table 1).
Against the bacterium E. clocae β12 the toxin showed activity at
50 μM. VdTX-I was not active against two microorganisms tested,
Candida parapsiliosis and Aspergillus niger.
A similar activity was observed when the toxin was tested in
dose-response curve against C. albicans MDM8, C. guillermondii
IOC4557,M. luteus A270 and E. coli ATCC 25922. It was observed an
inhibition of the growth of these microorganisms at concentra-
tions of 3.12 mM, reaching full growth inhibition at 100 μM of
toxin. (Fig. 1)
The incubation time that VdTX-I needed to act on micro-
organisms was determined by killing curve protocol against M.
luteus (gran positive) and E. coli D31 (gran negative). Our results
have shown that the toxin inhibits the growth of the bacteria M.
luteus after 5 min of exposure and E. coli D31 has its growth in-
hibited after 10 min exposure. For comparison, streptomycin takes
30 and 10 min against the same microorganisms, respectively
(Fig. 2).
The hemolysis test showed that VdTX-I was not able to cause
signiﬁcant hemolysis at concentrations from 0.19 to 100 μM, with
approximately 6% of hemolysis only at the highest concentration.
(Fig. 3)
The cytotoxic activity of VdTX-I was tested using the con-
centrations of 2.5 and 20 μg/mL, and only in the concentration of
20 mg/mL a low inhibitory activity has been found in K562 eri-
troleukemia cells. (Fig. 4)4. Discussion
Since antibiotics were introduced into clinical practice, bacter-
ial pathogens have developed resistance that might reduce their
effectiveness. Moreover, with opportunistic pathogens innate re-
sistance to antibiotics has become particularly problems arising in
hospital environments [22]. Thus, the research of new molecules
may provide an alternative for this scenario.
In general polyamines such as poly (ethyleneimines) (PEIs)
show strong antimicrobial activity against Gram-Positive bacteria,
Staphylococcus aureus, and Gram-Negative Bacteria, E. coli. How-
ever higher concentrations were required to destroy E. coli com-
pared to S. aureus[23].
This can be explained by differences in cell wall structure of
Gram-positive and Gram-negative bacteria. Gram-Positive micro-
organisms such as Staphylococcus aureus, has a relatively thickwall, but porous, as Gram-Negative bacteria such as E. coli, have an
outer membrane structure, forming a barrier to foreign molecules.
[23]
The VdTX-I toxin has its antimicrobial activity at a relatively
high MIC of 12.5 to 100 μM, but shows a wide-spectrum, being
active against gran negative and positive bacteria, fungi and yeasts.
Compared to antimicrobial peptides from other animal venoms,
they used to present a low MIC but an activity against few mi-
croorganisms, such as the Cupienin 1 (puriﬁed venom C. salei)
with MIC between 0.31 0.62 μM and active against four bacterial
species [24]. Furthermore, the Latarcins (1, 2a, 3a, 3b, 4a and 5)
puriﬁed from the venom of the spider Lachesana tarabaevi (Zo-
dariidae) also have a MIC between 0.5 and 2.9 μM. In this same
venom we can ﬁnd two other Latarcins (6a and 7) having anti-
microbial activity with MIC greater than 70 μM [25], showing a
similar activity to VdTX-I. Mygalin, an acylpolyamine from the
hemocytes of the spider Acanthoscurria gomesiana, was active only
against E. coli (MIC 85 mM) [26].
Antimicrobial peptides can be found in other animal venoms,
such as from Migainin-2 [24], derived from the venom of the skin
of african frog Xenopus laevis having MIC larger than 60 μM. High
activity antimicrobial peptides can also be found in the venoms of
scorpions. For example, BmKb1 (Mesobuthus martensii) with MIC
between 16 and 90 μM, and IsCT (Opisthacanthus madascarensis)
with MIC between 0.7 and 150 μM. Tityus serrulatus peptide that
may be greater than 150 μM, which have high MIC but a broad
spectrum of activity as VdTX-I, revealing that its activity is rela-
tively low [27].
The time that VdTX-I inhibits the growth of the bacteria E. coli
and M. luteus was 5 and 10 min, respectively, which reﬂects an
effect relatively slow when compared with La47, peptide isolated
from the venom of spider Lachesana sp, which has its action after
2 min of incubation against E. coli. The puriﬁed peptide from the
venom of the scorpion Centruroides suffusus suffusus, the Css54,
has its activity soon after the start of incubation time [28].
The low hemolytic activity displayed by VdTX-I, with 6% of
hemolysis with 100 μM toxin, is comparable to the one caused by
the peptide O-defensin, with 7% hemolysis after incubation under
36 μM [11]. On the other hand, the toxin LyeTx-I (puriﬁed from the
spider Lycosa erythrognatha) has a high hemolytic activity, with
40% hemolysis at 0.13 μM [29] and Css54 with approximately 65%
at 20 μM [28].
We did not observe the cytotoxicity of VdTX-I against K562
cells at the tested concentrations of 2.5 μg/mL, but at the con-
centration of 20 μg/mL, were observed a small activity. This may
be due to the fact that some polyamines such as poly-
hexamethylene biguanide (PHMB) did not affect eukaryotic cells.
R. Sutti et al. / Biochemistry and Biophysics Reports 4 (2015) 324–328328Since these cells have neutral phospholipids in the composition of
the membrane and polyamines have increased activity on phos-
pholipids acids present in the membranes of microorganisms [23].
Just as PHMB, VdTX-I also has selective action, making their cy-
totoxicity and irritation potential smaller than other antiseptics
[23]5. Conclusions
We can conclude that VdTX-I toxin has a signiﬁcant anti-
microbial activity and broad spectrum. Also is a toxin that acts
relatively fast against the tested bacteria. The VdTX-I toxin has low
hemolytic activity but is not active against tumor cells of a parti-
cular lineage.Conﬂicts of interest
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